Literature DB >> 2735336

Sucralfate interactions with gastric mucus.

C Tasman-Jones1, G Morrison, L Thomsen, M Vanderwee.   

Abstract

Sucralfate protects the stomach against a number of experimental damaging agents and is efficacious in the treatment of peptic ulcer disease. It binds with acidity to the base of an ulcer to form a protective barrier. Sucralfate also enhances prostaglandin synthesis and release in the mucosa. In this study, the rat stomach was examined to determine sucralfate's interaction with gastric mucus. Mucus in the rat stomach forms a distinct and continuous blanket. In snap-frozen samples, pretreatment with phosphate-buffered saline as a control shows a layer of mucus of homogeneous structure thinner than the homogeneous layer after pretreatment with antibodies developed against rat gastric mucus. Pretreatment with the surface protective agent sucralfate shows some increase in the thickness of mucus with a thin dense sublayer adjacent to the epithelium and a less dense-appearing outer zone of variable thickness. Analysis of x-rays generated by the electron beam on windows of mucus and epithelium showed the expected gradients of sodium, potassium, chloride, and sulfur. The percentage of aluminum and sulfur in the mucus was higher in sucralfate-treated samples than in controls. Interaction between sucralfate and gastric mucus needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735336     DOI: 10.1016/0002-9343(89)90149-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Sucralfate prevents the delay of wound repair in intestinal epithelial cells by hydrogen peroxide through NF-kappaB pathway.

Authors:  Kenichi Shindo; Masahiro Iizuka; Kenji Sasaki; Shiho Konno; Hiroaki Itou; Yasuo Horie; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

Review 2.  Clinical Drug-Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives.

Authors:  Suresh P Sulochana; Muzeeb Syed; Devaraj V Chandrasekar; Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

3.  A novel evaluation method of gastric mucoadhesive property in vitro and the mucoadhesive mechanism of tetracycline-sucralfate acidic complex for eradication of Helicobacter pylori.

Authors:  Shoichi Higo; Kazutomo Ori; Hirofumi Takeuchi; Hiromitsu Yamamoto; Tomoaki Hino; Yoshiaki Kawashima
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

4.  Effect of sucralfate on components of mucosal barrier produced by cultured canine epithelial cells in vitro.

Authors:  J M Scheiman; E R Kraus; K Yoshimura; C R Boland
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.